A randomised controlled trial on roles of prostaglandin E1 nebulization among patients undergoing one lung ventilation

A randomised controlled trial on roles of prostaglandin E1 nebulization among patients undergoing one lung ventilation

Abstract Background Prostaglandin E1 (PGE1) has been reported to maintain adequate oxygenation among patients under 60% FiO2 one-lung ventilation (OLV). This research aimed to explore whether PGE1 is safe in pulmonary shunt and oxygenation under 40% FiO2 OLV and provide a reference concentration of...

Full description

Bibliographic Details
Main Authors: Pengyi Li, Lianbing Gu, Jing Tan, Zhenghuan Song, Qingming Bian, Dian Jiao, Zeping Xu, Lijun Wang
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Pulmonary Medicine
Subjects:
Prostaglandin E1
One-lung ventilation
40% FiO2
Randomised controlled trial
Online Access:https://doi.org/10.1186/s12890-022-01831-4

Internet

https://doi.org/10.1186/s12890-022-01831-4

Similar Items